1. Home
  2. NUTX vs AVLN Comparison

NUTX vs AVLN Comparison

Compare NUTX & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

N/A

Current Price

$191.49

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$38.58

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUTX
AVLN
Founded
2011
N/A
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2009
2026

Fundamental Metrics

Financial Performance
Metric
NUTX
AVLN
Price
$191.49
$38.58
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$252.50
N/A
AVG Volume (30 Days)
120.9K
175.8K
Earning Date
04-30-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
7.93
N/A
EPS
15.87
N/A
Revenue
$875,257,000.00
N/A
Revenue This Year
$6.12
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
$11.87
N/A
Revenue Growth
82.36
N/A
52 Week Low
$77.21
$24.90
52 Week High
$204.00
$39.99

Technical Indicators

Market Signals
Indicator
NUTX
AVLN
Relative Strength Index (RSI) 60.19 71.28
Support Level $146.07 $26.38
Resistance Level $195.52 $39.99
Average True Range (ATR) 13.84 2.24
MACD 3.57 1.01
Stochastic Oscillator 79.05 89.68

Price Performance

Historical Comparison
NUTX
AVLN

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: